JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1995) 15, 73-79    DOI: 10.1677/jme.0.0150073
© 1995 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monden, T
Right arrow Articles by Mori, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monden, T
Right arrow Articles by Mori, M

Transcriptional down-regulation by epidermal growth factor of TRH receptor mRNA in rat pituitary cells

T Monden, M Yamada, S Konaka, T Satoh, H Ezawa, T Iwasaki and M Mori

To gain insight into the mechanism underlying the epidermal growth factor (EGF)-induced changes in responsiveness to TRH and in the numbers of TRH receptors (TRH-Rs) in the pituitary, we investigated the transcriptional regulation by EGF of the TRH-R gene in GH4C1 cells. Northern blot analyses and binding studies revealed that EGF reduced both TRH binding and TRH-R mRNA levels in a dose- and time-dependent manner, while no significant changes were observed in β-actin mRNA levels. Addition of actinomycin D caused an acute increase in the basal TRH-R mRNA level, and the rate of decrease of the TRH-R mRNA was identical in control and EGF-treated groups, suggesting that the stability of the TRH-R mRNA was not significantly affected in EGF-treated cells. Incubation with cycloheximide also induced an increase in the basal TRH-R mRNA level and completely reversed the EGF-induced reduction of TRH-R mRNA levels. Furthermore, a nuclear run-on assay demonstrated that the rate of transcription of the TRH-R gene was significantly inhibited in cells treated with EGF. We conclude that (1) EGF decreases the expression of the TRH-R mRNA largely by reducing its rate of transcription, and this action requires the synthesis of new proteins, and (2) inhibitors of protein and RNA synthesis cause a significant increase in the basal TRH-R mRNA level, suggesting that there may be a short-lived protein suppressing the TRH-R mRNA level in the pituitary.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Schwartz
Intercellular Communication in the Anterior Pituitary
Endocr. Rev., October 1, 2000; 21(5): 488 - 513.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Iwasaki, M. Yamada, T. Satoh, S. Konaka, Y. Ren, K. Hashimoto, H. Kohga, Y. Kato, and M. Mori
Genomic Organization and Promoter Function of the Human Thyrotropin-releasing Hormone Receptor Gene
J. Biol. Chem., September 6, 1996; 271(36): 22183 - 22188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Thomson, J. T. Rogers, and P. J. Leedman
Thyrotropin-releasing Hormone and Epidermal Growth Factor Regulate Iron-regulatory Protein Binding in Pituitary Cells via Protein Kinase C-dependent and -independent Signaling Pathways
J. Biol. Chem., October 6, 2000; 275(41): 31609 - 31615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society for Endocrinology.